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ABSTRACT
Objective: To compare the thrombolytic activity of Curcuma amada and Curcuma caesia.
Methods: Hydroalcoholic extractions of C. amada and C. caesia were prepared. Clot lysis potential of the extracts was checked, and the results were 
statistically analyzed.
Results and Conclusion: On comparing the thrombolytic potential, the percentage of clot lysis of synthesized silver nanoparticle using C. caesia 
(51%) was found to be higher than C. amada (34.7%) extract. Similarly, C. caesia extract (38.75±2.217) showed higher percentage of clot lysis than 
C. amada (34.74±6.074). The mean percentage of clot lysis of rhizome extracts and synthesized silver nanoparticle was statistically more significant 
(p<0.05) when compared to the positive control streptokinase and negative control water. Active component involvement analysis will be helpful to 
utilize the C. amada and C. caesia as potent therapeutic agent.
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INTRODUCTION
Active ingredients of medicinal plants are used in the synthesis of 
different drugs. Many of the laxatives, anticoagulants, antibiotics, and 
antimalarial drugs contain ingredients from plants [1]. The family 
Zingiberaceae has much medicinal value, and it is distributed widely 
throughout the Southeast Asian region. Gingers are important natural 
source, used as a raw material for the production of food, spices, 
medicines, dyes, perfume, etc. The ginger family comprises 53 genera 
and over 1200 species. India is one of the richest and diverse regions 
for Zingiberaceae, having 20 genera and around more than 200 species. 
The members of Zingiberaceae are annual or perennial rhizomatous 
herbs [2].
Mango ginger (Curcuma amada) is famous due to its raw aroma 
which belongs to Zingiberaceae family [3]. Various study reports 
revealed that the mango ginger has wide pharmacological properties 
such as antidiabetic, immunomodulatory, antioxidant, antitumor, and 
hepatoprotective effects [4]. In India, the Curcuma caesia rhizomes are 
used in the treatment of sprains and bruises and also in the preparation 
of cosmetics [5]. Black turmeric powder is utilized by the tribes of 
Nadia of West Bengal, to treat certain illnesses such as fevers, stomach 
problems, allergies, diarrhea, chronic cough, heartburn, and for various 
other ailments [6]. Various studies revealed that the presence of 
flavonoids and phenolic compounds in plants are responsible for the 
antioxidant, anti-inflammatory, and anticarcinogenic activity [7].
Plants exert thrombolytic effects due to the presence of certain 
fibrinolytic protease enzymes. Plasmin is formed from its zymogen 
by plasminogen activators such as urokinase (UK)-type plasminogen 
or tissue-type plasminogen activator [8,9]. Plasmin cleaves the fibrin 
network supporting blood clots and restores blood flow to the affected 
tissue [8]. Heart disease caused by blood clot (thrombus) formation 
is the most severe disease which is increasing at an alarming rate in 
the recent years. Thrombolytic agents are used to lyse the clot and in 
the management of thrombosis in patients. UK, streptokinase (SK), 
etc., are the tissue plasminogen activator (t-PA) used for the treatment 
of thrombosis, but their usage is found to cause side effects [10]. In 
the present study, the thrombolytic activity of C. amada and C. caesia 




C. amada and C. caesia were commercially brought from Local Siddha 
Medical Shop, Chennai. Sample collected was authenticated and 
deposited in the Department of Biotechnology, Faculty of Science and 
Humanities, SRM University.
Hydroalcoholic extraction
10 g of fresh rhizome of both C. amada and C. caesia was cut into 
small pieces, placed in 100 ml of hydroalcoholic solvent (70 ml 
alcohol, 30 ml water) and left for 7 days with occasional shaking (cold 
maceration) [11]. The extract was filtered, processed, and stored.
Thrombolytic activity
2 ml of venous blood (n=4) was drawn from healthy human volunteers 
without a history of oral contraceptive or anticoagulant therapy 
which were taken into different pre-weighed sterile microfuge tube. 
The microfuge tubes were incubated at 37°C for 45 minutes. Serum 
was removed without disturbing the clot and each tube weighed 
again to determine the clot weight (clot weight=Weight of clot 
containing tube − Weight of tube alone). Then, to each of the microfuge 
tube containing clot, 100 μl of C. caesia rhizome extract, 100 μl of 
synthesized silver nanoparticle using C. caesia rhizome extract, 100 μl 
of C. amada rhizome extract, 100 μl of silver nanoparticle of C. amada 
rhizome extract, 100 µl of SK (positive control), and 100 μl of distilled 
water (negative control) were separately added. All the tubes were 
then incubated for 90 minutes at 37°C, and clot lysis was analyzed. 
After incubation, the fluid was discarded, tubes were weighed, and the 
difference in weight after clot disruption was marked [10,12]. Finally, 
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percentage of clot lysis was determined as percentage of clot lysis = 
(Weight of released clot/clot weight) × 100.
Statistical analysis
All the results obtained were expressed as mean±standard error of 
mean. The data for the sample were analyzed using Mann–Whitney 
(Non parametric Statistic for sample size that is usually small). p<0.05 
was considered statistically significant [12].
RESULTS AND DISCUSSION
Numbers of drugs approved by the Food and Drug Administration 
currently have plant origins. The existing proof shows that consuming 
food supplements having anticoagulant, antiplatelet, and fibrinolytic 
activity leads to prevention of coronary diseases [13]. In the present 
study, thrombolytic activity analysis of C. amada and C. caesia rhizome 
extract showed removal of clot by 34.74% and 38.75%, respectively, 
with that of positive control SK of 77.93% and negative control 
of 7.1% clot lysis (Fig. 1). In the earlier work, we synthesized and 
characterized silver nanoparticle using hydroalcoholic extracts of C. 
amada and C. caesia [14]. The silver nanoparticle synthesis was used 
for analyzing the thrombolytic potential along with the extracts. The 
comparative study reveals that the silver nanoparticle of C. caesia had 
high potential to lyse the clot than the silver nanoparticle of C. amada 
and the rhizome extracts (Fig. 2). The available proof for the non-
toxicity of silver nanoparticle will bring improvements in the treatment 
of thrombosis [15,16]. Statistical analysis revealed that the rhizome 
extracts have a significant percentage of clot lysis when compared 
with positive and negative control. As the first generation drugs (SK 
and UK), found to cause side effects [17], plant-based thrombolytic 
drugs will improve the treatment of thrombosis. Therefore, in-vivo 
study of C. amada and C. caesia is further needed, to be recognized as a 
thrombolytic agent.
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Fig. 1: Clot lysis
Fig 2: Comparative thrombolytic activity of rhizome extracts and 
synthesized silver nanoparticle of Curcuma amada and Curcuma 
caesia expressed as percentage of clot lysis
